Global biotech firm founded in 1989 in Bergisch Gladbach, providing tools and instruments for cell and gene therapy, from research to clinical application.
Miltenyi Biotec is a global biotechnology company founded in 1989 in Bergisch Gladbach, Germany, by Stefan Miltenyi, who remains its chief executive. The privately held firm develops integrated solutions spanning the full path from basic research to clinical application in cell and gene therapy, covering sample preparation, cell isolation, flow cytometry and molecular analysis.
Its technical work sits at the intersection of biomedicine and engineering. Key domains include magnetic cell sorting, cell isolation, flow cytometry, molecular analysis, cellular therapies, personalised medicine, biomedical engineering and instrument development. MACS® Technology, the magnetic cell sorting process devised by the founder in 1989, remains the company's foundational platform. CliniMACS Prodigy, an automated instrument, is used in cell and gene therapy and other clinical applications.
Miltenyi Biotec employs more than 4,900 people and operates in over 50 countries. Its work serves life sciences research, pharmaceutical and biomedical research, clinical diagnostics, cancer research and personalised medicine. The company states a mission of "making cancer history" and describes its purpose as empowering researchers and clinicians.
